跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AURO-NITROFURANTOIN BID - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AURO-NITROFURANTOIN BID
Authorized
STANDARD
AURO-NITROFURANTOIN BID
auro pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ad331499a702aecb
Company
auro pharma inc
Type
Standard
Approval Details
Approval Id
ad331499a702aecb
Drug Approval Canada Name
AURO-NITROFURANTOIN BID
Product Name
AURO-NITROFURANTOIN BID
Status
Marketed
Status Date
2020-09-09
Original Market Date
2017-10-23
Din
02466392
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:36.00
Atc Original
J01XE01 NITROFURANTOIN
Atc Name
j 01 xe 01
Aig Number
0101480001
Company Name
auro pharma inc
Company Address
3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8
Active Ingredients
NITROFURANTOIN
100 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ad331499a702aecb
Type
Standard
Back to Health Canada Approvals